Spherity's Credentialing Service, known as CARO, is a digital identity solution designed to streamline compliance with the U.S. Drug Supply Chain Security Act (DSCSA. It enables pharmaceutical supply chain participants to verify the authorized status of trading partners, ensuring secure and efficient interactions. By integrating CARO, businesses can automate the management of trading partner credentials, reducing manual processes and enhancing data accuracy. Key Features and Functionality: - Trading Partner Identity Management: Provides identity credentials compliant with PDG, OCI, and NIST standards, ensuring secure and standardized partner verification. - Digital Credentials for ATP Status: Facilitates the demonstration and verification of Authorized Trading Partner (ATP status using digital credentials, as recommended by PDG, GS1, and NCPA. - Interoperable Verification and Tracing: Seamlessly integrates with Verification Router Service (VRS and tracing providers, allowing for efficient verification and traceability without altering existing IT systems. - License Status Verification: Enables the checking of trading partners' license numbers to confirm their authorized status. - Master Data Management: Allows for the creation and monitoring of a comprehensive address book of trusted parties, ensuring consistency and accuracy of master data across the organization. Primary Value and Problem Solved: CARO addresses the critical need for compliance with DSCSA regulations by automating the verification of trading partners' authorized status. This automation reduces the risk of non-compliance, minimizes manual errors, and enhances the security of the pharmaceutical supply chain. By providing a single source of truth for trading partner data, CARO ensures that businesses can confidently engage with verified partners, thereby protecting patient safety and maintaining regulatory adherence.